Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage
Annarita Nappi(Federico II University Hospital), Monica Dentice(Federico II University Hospital), Gabriella Fabbrocini(Universitätsklinik für Chirurgie Wien), Antonio Pezone(University of Naples Federico II), Caterina Miro(University of Naples Federico II), Giuseppina Caiazzo(University of Naples Federico II), Mariano Stornaiuolo(University of Naples Federico II), Domenico Salvatore(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Alfonso Tramontano(University of Campania "Luigi Vanvitelli"), Elena Abbotto(University of Genoa), Enrico Avvedimento(University of Naples Federico II), Serena Sagliocchi(University of Naples Federico II), Annunziata Gaetana Cicatiello(University of Naples Federico II), Emery Di Cicco(Federico II University Hospital), Sepehr Torabinejad(University of Naples Federico II), Melania Murolo(University of Naples Federico II), Maddalena Raia(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Dario Antonini(Federico II University Hospital)
Cited by 35
Related Papers
ROS in cancer therapy: the bright side of the moon
|Experimental & Molecular Medicine|2020|2.2k
What causes hidradenitis suppurativa ?—15 years after
|Experimental Dermatology|2020|190
Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*
|British Journal of Dermatology|2020|175
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
|The Journal of Clinical Endocrinology & Metabolism|2017|155
Advances in Immunotherapy for Melanoma: A Comprehensive Review
|Mediators of Inflammation|2017|143